Autocrine motility factor receptor expression implies an unfavourable prognosis in resected stage I pulmonary adenocarcinomas


Kaynak K., Kara M., Oz B. , Akgoz B., Sar M., Raz A.

ACTA CHIRURGICA BELGICA, vol.105, no.4, pp.378-382, 2005 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 105 Issue: 4
  • Publication Date: 2005
  • Doi Number: 10.1080/00015458.2005.11679740
  • Title of Journal : ACTA CHIRURGICA BELGICA
  • Page Numbers: pp.378-382

Abstract

Background : Pulmonary adenocarcinomas constitute a different histological subtype among the histological subtypes of non small cell lung carcinomas by showing comparably unfavourable rates of prognosis and different immunobiological features. Autonomous motility of tumour cells plays an important role in the regulation of local invasion and distant metastasis of tumour lesions which have great impact on overall survival. AMF (Autocrine motility factor) is a tumour secreted cytokine that stimulates motility during invasion and metastasis via its receptor, AMFR. We conducted an immunohistochemical study to investigate AMFR expression in pulmonary adenocarcinomas and its effect on survival.